Jwa Kum Whan Attenuates Nonalcoholic Fatty Liver Disease by Modulating Glucose Metabolism and the Insulin Signaling Pathway.
Evid Based Complement Alternat Med
; 2019: 4589810, 2019.
Article
in En
| MEDLINE
| ID: mdl-30881473
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Evid Based Complement Alternat Med
Year:
2019
Document type:
Article
Country of publication: